NCT05016310 2025-07-23
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
Wake Forest University Health Sciences
Phase NA Completed
Clinical Trials
31 trialsNCT00963417 2025-07-14
TEXT-Bone
ETOP IBCSG Partners Foundation
Phase NA Completed
NCT01144468 2024-03-27
MAP3BSS
University Health Network, Toronto
Completed
NCT00688246 2023-08-04
Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3
Canadian Cancer Trials Group
Completed
NCT05970250 2023-08-01
Effect Of Whole Body Vibration Versus Weight Bearing Exercises On Osteoporosis In Breast Cancer Patients After Chemotherapy
Cairo University
Phase NA Completed
NCT02455154 2020-04-14
COAT
Shanghai Jiao Tong University School of Medicine
Phase 2 Completed
NCT00354302 2020-04-02
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
Canadian Cancer Trials Group
Phase 3 Completed
NCT00340262 2020-03-30
Bone Mineral Density and Subsequent Cancer Risk
National Institutes of Health Clinical Center (CC)
Completed
NCT00305695 2020-03-24
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
GOG Foundation
Phase 2 Completed
NCT00436917 2019-09-11
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Mayo Clinic
Phase NA Completed
NCT00639210 2019-02-26
BREX
Finnish Breast Cancer Group
Phase 3 Completed
NCT00111241 2018-12-14
Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors
Monash University
Completed
NCT00485953 2017-10-13
REBBeCA II
University of Pittsburgh
Phase 4 Completed
NCT02484131 2017-03-27
Bone Health Management for Women Diagnosed With Breast Cancer
University of British Columbia
Phase NA Completed
NCT00107263 2016-12-06
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00022087 2016-07-19
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00054418 2016-07-13
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01277562 2015-06-08
Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer
City of Hope Medical Center
Completed
NCT00049452 2014-01-06
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00859703 2013-10-31
RISAROS
Hospices Civils de Lyon
Phase 3 Completed
NCT00114270 2013-03-26
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
National Cancer Institute (NCI)
Phase NA Completed
NCT00766532 2012-09-14
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
University of Wisconsin, Madison
Phase 4 Completed
NCT00369850 2012-07-27
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT00031811 2012-05-28
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00332709 2011-11-16
Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
Novartis
Phase 3 Completed
NCT00005605 2011-02-21
Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
Northwestern University
Completed
NCT00082277 2011-01-26
SABRE
AstraZeneca
Phase 4 Completed
NCT00252408 2009-09-04
Danish Osteoporosis Prevention Study
University of Aarhus
Phase 4 Completed
NCT00767585 2009-07-03
An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice
AstraZeneca
Completed
NCT00587925 2009-02-26
Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00010829 2006-08-18
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
National Center for Complementary and Integrative Health (NCCIH)
Phase 2 Completed